Tidewater Physicians Multispecialty Group Clinical Research

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer1 trial
• Crohn's disease1 trial

Phase

• Phase 31 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Eli Lilly and Company1 trial
• Guardant Health, Inc.1 trial

Running trials

• Active, not recruiting

  A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

  NCT04232553· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

  NCT04136002· Guardant Health, Inc.· Source